[2-chlor-4-azaphenthiazine. Synthesis and pharmacological properties of cloxypendyl].
D000014:Abnormalities, Drug-Induced; D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001337:Autonomic Agents / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000187:drug effects; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002375:Catalepsy / Q000139:chemically induced; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D004361:Drug Tolerance; D004558:Electric Stimulation; D005260:Female; D005298:Fertility / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007022:Hypotension / Q000517:prevention & control; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009068:Movement / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010640:Phenothiazines / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy
D001337:Autonomic Agents; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D000109:Acetylcholine; D002746:Chlorpromazine; D009638:Norepinephrine
2-Chlor-4-azaphenthiazine. Synthese und pharmakologische Eigenschaften von Cloxypendyl.